The present invention is in the field of drug delivery and specifically cationic liposome-based drug delivery. In embodiments this invention provides methods of making ligand-targeted (e.g. antibody- or antibody fragment-targeted) liposomes useful for the delivery of liposomes to tumors including brain tumors. In embodiments the liposomes deliver temozolomide across the blood-brain barrier for treatment of primary or metastatic brain tumors. Additional cancers that can be treated with the liposo...

The present invention discloses an ophthalmic composition for ophthalmic application(s) inclusive of Eye examination surgeries carried out in the posterior chamber of the Eye like cataract surgery. The said composition comprises at least three active ingredients. The said ingredients may be inclusive of but not restricted to Epinephrine Bitartrate Atropine Bisulphate Xylocaine Hydrochloride and additives like antioxidant compounds buffers and the like. The said composition comes in a packaging c...

The present invention discloses an ophthalmic composition for ophthalmic application(s) inclusive of Eye examination surgeries carried out in the posterior chamber of the Eye like cataract surgery. The said composition comprises at least three active ingredients. The said ingredients may be inclusive of but not restricted to Epinephrine Bitartrate Atropine Bisulphate Xylocaine Hydrochloride and additives like antioxidant compounds buffers and the like. The said composition comes in a packaging c...

The present invention discloses an ophthalmic composition for ophthalmic application(s) inclusive of Eye examination, surgeries carried out in the posterior chamber of the Eye like cataract surgery. The said composition comprises at least three active ingredients. The said ingredients may be inclusive of, but not restricted to, Epinephrine Bitartrate, Atropine Bisulphate, Xylocaine Hydrochloride and additives like, antioxidant compounds, buffers and the like. The said composition comes in a pack...

Compositions for therapy of a diabetic symmetrical polyneuropathy a subject in need thereof the compositions comprising: an effective amount of a muscarinic acetylcholine receptor antagonist exemplified by pirenzepine telenzepine atropine or derivatives thereof or salts thereof or analogs thereof or derivatives thereof and a pharmacologically acceptable carrier. The composition may be injectable or alternatively may be applied topically or alternatively may be delivered orally. A suitable topica...

Compositions for therapy of a diabetic symmetrical polyneuropathy a subject in need thereof, the compositions comprising: an effective amount of a muscarinic acetylcholine receptor antagonist exemplified by pirenzepine, telenzepine, atropine, or derivatives thereof or salts thereof or analogs thereof or derivatives thereof, and a pharmacologically acceptable carrier. The composition may be injectable or alternatively, may be applied topically or alternatively, may be delivered orally. A suitable...